Literature DB >> 6482979

Detection of impending intravascular thrombosis prior to the clinically overt event.

L Pilgeram.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6482979     DOI: 10.1007/bf00410745

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


× No keyword cloud information.
  8 in total

1.  Relation of plasma fibrinogen concentration changes to human arteriosclerosis.

Authors:  L O PILGERAM
Journal:  J Appl Physiol       Date:  1961-07       Impact factor: 3.531

2.  Thrombosis as a factor in the pathogenesis of coronary atherosclerosis.

Authors:  J B DUGUID
Journal:  J Pathol Bacteriol       Date:  1946-04

3.  Pathogenesis of atherosclerosis.

Authors:  J B DUGUID
Journal:  Lancet       Date:  1949-11-19       Impact factor: 79.321

4.  Evidence for abnormalities in clotting and thrombolysis as a risk factor for stroke.

Authors:  L O Pilgeram; A N Chee; G Von dem Bussche
Journal:  Stroke       Date:  1973 Jul-Aug       Impact factor: 7.914

5.  Abnormalities in clotting and thrombolysis as a risk factor for stroke.

Authors:  L O Pilgeram
Journal:  Thromb Diath Haemorrh       Date:  1974-05-15

6.  Turnover rate of autologous plasma fibrinogen-14C in subjects with coronary thrombosis.

Authors:  L O Pilgeram
Journal:  Thromb Diath Haemorrh       Date:  1968-11-15

7.  Control of intravascular fibrin formation: heparin versus coumarin congeners.

Authors:  L O Pilgeram
Journal:  Thromb Res       Date:  1981 Dec 1-15       Impact factor: 3.944

8.  Haemostatic factors and coronary heart disease.

Authors:  L O Pilgeram
Journal:  Biomed Pharmacother       Date:  1982       Impact factor: 6.529

  8 in total
  2 in total

Review 1.  Atherogenesis and fibrinogen: historical perspective and current status.

Authors:  L Pilgeram
Journal:  Naturwissenschaften       Date:  1993-12

2.  Control of fibrinogen biosynthesis: role of the FFA/albumin ratio.

Authors:  Laurence Pilgeram
Journal:  Cardiovasc Eng       Date:  2010-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.